An international team, including researchers from McMaster University and St. Joseph’s Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA).
Who’s at greater risk for long-COVID? New study sheds light on vulnerable demographics
A study analyzing 134,444 participants from BRFSS and NHIS reveals that 21.5% and 17.1% respectively suffer from long-COVID, with higher risks in middle-aged, female, Hispanic
January 18, 2024